Maccura Biotechnology Co Ltd

Price Chart

Risk-Adjusted Performance

Maccura Biotechnology Co Ltd (300463) Price Performance

Maccura Biotechnology Co Ltd (300463) trades on SHE in CNY. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at CNY10.65, down 1.93% from the previous close.

Over the past year, 300463 has traded between a low of CNY10.60 and a high of CNY14.20. The stock has lost 9.3% over this period. It is currently 25.0% below its 52-week high.

Maccura Biotechnology Co Ltd has a market capitalization of $6.44B, with a price-to-earnings ratio of 50.78 and a dividend yield of 0.96%.

About Maccura Biotechnology Co Ltd

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system. Maccura Biotechnology Co.Ltd was founded in 1994 and is headquartered in Chengdu, China.

Compare Maccura Biotechnology Co Ltd

Side-by-side comparison against top Healthcare peers.